A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
- PMID: 8293467
- DOI: 10.1016/0092-8674(94)90340-9
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Abstract
Acute promyelocytic leukemia (APL) is associated with a t(15;17) translocation that creates the promyelocyte-retinoic acid receptor alpha (PML-RAR alpha) fusion gene. Immunohistochemistry demonstrates that PML is a part of a novel macromolecular organelle (including at least three other nuclear proteins) referred to as PML oncogenic domains (PODs). In APL cells, the POD is disrupted into a microparticulate pattern as a consequence of the expression of the PML-RAR oncoprotein. RA treatment of APL cells triggers a reorganization of PML to generate normal-appearing PODs. We propose that PML-RAR is a dominant negative oncoprotein that exerts its putative leukomogenic effect by inhibiting assembly of the POD. According to this proposal, not only is the POD a novel structure, but it can be ascribed an imputed function such that its disruption leads to altered myeloid maturation; this may represent a novel oncogenic target.
Similar articles
-
Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.Oncogene. 1995 Jun 15;10(12):2307-14. Oncogene. 1995. PMID: 7784078
-
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.Cell. 1994 Jan 28;76(2):345-56. doi: 10.1016/0092-8674(94)90341-7. Cell. 1994. PMID: 8293468
-
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.Curr Top Microbiol Immunol. 1997;220:81-112. doi: 10.1007/978-3-642-60479-9_6. Curr Top Microbiol Immunol. 1997. PMID: 9103677 Review.
-
cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.Oncogene. 1996 Jun 6;12(11):2451-9. Oncogene. 1996. PMID: 8649787
-
Acute promyelocytic leukemia: from clinic to molecular biology.Stem Cells. 1995 Jan;13(1):22-31. doi: 10.1002/stem.5530130104. Stem Cells. 1995. PMID: 7719245 Review.
Cited by
-
PML Degradation: Multiple Ways to Eliminate PML.Front Oncol. 2013 Mar 22;3:60. doi: 10.3389/fonc.2013.00060. eCollection 2013. Front Oncol. 2013. PMID: 23526763 Free PMC article.
-
Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.World J Gastroenterol. 2015 Jan 7;21(1):283-91. doi: 10.3748/wjg.v21.i1.283. World J Gastroenterol. 2015. PMID: 25574103 Free PMC article.
-
Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia.Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2406519121. doi: 10.1073/pnas.2406519121. Epub 2024 Aug 13. Proc Natl Acad Sci U S A. 2024. PMID: 39136995
-
Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.J Virol. 1999 Oct;73(10):8308-19. doi: 10.1128/JVI.73.10.8308-8319.1999. J Virol. 1999. PMID: 10482581 Free PMC article.
-
Large-scale isolation of Cajal bodies from HeLa cells.Mol Biol Cell. 2002 Jul;13(7):2461-73. doi: 10.1091/mbc.02-03-0034. Mol Biol Cell. 2002. PMID: 12134083 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases